Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice.
暂无分享,去创建一个
J. Obata | Takamitsu Nakamura | D. Fujioka | Yosuke Watanabe | Kazuhiro Watanabe | K. Kugiyama | Yukio Saito | K. Kawabata | K. Hanasaki | Hideto Mishina | Shun Tamaru | Daisuke Fujioka
[1] M. Gelb,et al. Group X Secretory Phospholipase A2 Enhances TLR4 Signaling in Macrophages , 2011, The Journal of Immunology.
[2] A. Gabrielsen,et al. Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm , 2010, Proceedings of the National Academy of Sciences.
[3] Jean-Baptiste Michel,et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.
[4] M. Gelb,et al. Group X Secretory Phospholipase A2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in Macrophages , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[5] D. Waters,et al. Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. , 2010, Journal of the American College of Cardiology.
[6] M. Triggiani,et al. Lung mast cells are a source of secreted phospholipases A2. , 2009, The Journal of allergy and clinical immunology.
[7] J. Michel,et al. Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophilderived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] J. H. van Bockel,et al. Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic T Cells , 2009, Circulation.
[9] Heather L Rick,et al. Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE−/− Mice , 2009, Journal of cardiovascular pharmacology.
[10] Takamitsu Nakamura,et al. Reduction in Myocardial Ischemia/Reperfusion Injury in Group X Secretory Phospholipase A2–Deficient Mice , 2008, Circulation.
[11] Robert W. Thompson,et al. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms , 2007, Proceedings of the National Academy of Sciences.
[12] G. le Naour,et al. Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] W. Cho,et al. Systematic Evaluation of Transcellular Activities of Secretory Phospholipases A2 , 2006, Journal of Biological Chemistry.
[14] M. Murakami,et al. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. , 2005, Biochimica et biophysica acta.
[15] T. Wakefield,et al. L-Selectin–Mediated Neutrophil Recruitment in Experimental Rodent Aneurysm Formation , 2005, Circulation.
[16] B. Baxter,et al. Elastin Degradation and Calcification in an Abdominal Aorta Injury Model: Role of Matrix Metalloproteinases , 2004, Circulation.
[17] Makoto Murakami,et al. Secretory phospholipase A2. , 2004, Biological & pharmaceutical bulletin.
[18] B. L. Diaz,et al. Phospholipase A(2). , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[19] J. Balsinde,et al. Phospholipase A2 regulation of arachidonic acid mobilization , 2002, FEBS letters.
[20] Katsutoshi Yamada,et al. Potent Modification of Low Density Lipoprotein by Group X Secretory Phospholipase A2 Is Linked to Macrophage Foam Cell Formation* , 2002, The Journal of Biological Chemistry.
[21] M. Gelb,et al. Groups IV, V, and X Phospholipases A2s in Human Neutrophils , 2002, The Journal of Biological Chemistry.
[22] W. Pearce,et al. Murine aortic aneurysm produced by periarterial application of calcium chloride. , 2001, The Journal of surgical research.
[23] M. Murakami,et al. Cellular components that functionally interact with signaling phospholipase A(2)s. , 2000, Biochimica et biophysica acta.
[24] N. Fujii,et al. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. , 2000, Archives of biochemistry and biophysics.
[25] M. Gelb,et al. Exogenously Added Human Group X Secreted Phospholipase A2 but Not the Group IB, IIA, and V Enzymes Efficiently Release Arachidonic Acid from Adherent Mammalian Cells* , 2000, The Journal of Biological Chemistry.
[26] K. Kawamoto,et al. Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia Cells* , 1999, The Journal of Biological Chemistry.
[27] M. Gelb,et al. On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. , 1999, The Journal of biological chemistry.
[28] J. Tischfield. A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals* , 1997, The Journal of Biological Chemistry.
[29] J. Mudgett,et al. A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains (*) , 1995, The Journal of Biological Chemistry.
[30] P. Braquet,et al. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet‐activating factor in human neutrophils , 1994, British journal of pharmacology.
[31] S. Parikh,et al. Role of the Neutrophil in Abdominal Aortic Aneurysm Development , 1993, Cardiovascular surgery.
[32] M. Gelb,et al. Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. , 2011, Atherosclerosis.
[33] N. Weintraub,et al. Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[34] A. Daugherty,et al. Abdominal Aortic Aneurysms : Pathophysiological Mechanisms and Clinical Implications , 2004 .
[35] E. Dennis,et al. Phospholipase A2 , 1990, Advances in Experimental Medicine and Biology.